お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:瘢痕治療の世界市場:治療タイプ、瘢痕タイプ、エンドユーザー別 - 2030年までの業界分析と成長予測
市場調査レポート
商品コード
971169

瘢痕治療の世界市場:治療タイプ、瘢痕タイプ、エンドユーザー別 - 2030年までの業界分析と成長予測

Scar Treatment Market Research Report: By Treatment Type, Scar Type, End User - Global Industry Analysis and Growth Forecast to 2030

出版日: | 発行: Prescient & Strategic Intelligence Private Limited | ページ情報: 英文 205 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.15円
瘢痕治療の世界市場:治療タイプ、瘢痕タイプ、エンドユーザー別 - 2030年までの業界分析と成長予測
出版日: 2020年09月01日
発行: Prescient & Strategic Intelligence Private Limited
ページ情報: 英文 205 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の瘢痕治療市場は過去数年間で急速に成長しており、成長要因として、皮膚病の発生率の上昇、容貌や外見に対する人々の意識の高まり、瘢痕治療の認識の高まり、瘢痕治療における急速な技術の進歩と革新、可処分所得の増加などが挙げられます。また、同市場は、今後も急速な拡大を遂げると予測されています。

当レポートは、世界の瘢痕治療市場について調査しており、市場規模、動向や機会、成長および抑制要因、治療タイプ・瘢痕タイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査の背景

  • 調査目的
  • 市場の定義
  • 調査範囲
    • 治療タイプ別
    • 瘢痕タイプ別
    • エンドユーザー別
    • 地域別
  • 分析期間
  • 市場データレポーティングユニット
  • 主要な利害関係者

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 市場セグメントの定義
    • 治療タイプ別
      • 局所
      • 表面
      • レーザー
      • 注射
      • 手術
    • 瘢痕タイプ別
      • 萎縮性およびニキビ性瘢痕
      • ケロイドと肥厚性瘢痕
      • 瘢痕拘縮
      • ストレッチマーク
    • エンドユーザー別
      • 家庭
      • 病院
      • 皮膚科クリニック
      • その他
  • 市場力学
    • 動向
      • シリコーンベースの瘢痕治療製品の需要の増加
      • 瘢痕治療製品のオンライン小売りの台頭
    • 成長要因
      • 皮膚病の有病率の増加
      • 消費者の外見意識の高まり
      • 瘢痕治療の技術的進歩
      • 瘢痕治療に対する個人の意識の高まり
      • 可処分所得の急増
      • 市場予測に対する成長要因の影響分析
    • 抑制要因
      • 瘢痕治療製品と治療法の副作用
      • 瘢痕治療製品に関連する高いコスト
      • 市場予測に対する抑制要因の影響分析
    • 市場機会
      • 有機性瘢痕治療製品の需要増加
  • ポーターのファイブフォース分析
  • COVID-19の影響

第5章 世界の市場規模と予測

  • 治療タイプ別
    • 局所
    • 表面
    • レーザー
    • 注射
  • 瘢痕タイプ別
  • エンドユーザー別
  • 地域別

第6章 北米の市場規模と予測

第7章 欧州の市場規模と予測

第8章 アジア太平洋地域の市場規模と予測

第9章 ラテンアメリカの市場規模と予測

第10章 中東・アフリカの市場規模と予測

第11章 競合情勢

  • 主要企業の製品ベンチマーク
  • 戦略的開発
    • 製品の発売と承認
    • 買収
    • その他の開発

第12章 企業プロファイル

  • Hologic Inc.
  • Candela Corporation
  • Avita Medical Limited
  • Molnlycke Health Care AB
  • Shanghai Fosun Pharmaceutical (Group) Company Limited
  • Smith & Nephew plc
  • Revitol Corporation
  • Sonoma Pharmaceuticals Inc.
  • CCA Industries Inc.
  • Scarguard Labs LLC
  • Quantum Inc.
  • Bausch Health Companies Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Johnson & Johnson

第13章 付録

  • 略語
  • 情報とリファレンス
  • 関連レポート
図表

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 HOUSEHOLD DISPOSABLE INCOME NET ANNUAL GROWTH RATE (%) (2018)
  • TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 AVERAGE COST OF DIFFERENT SCAR TREATMENTS
  • TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 6 GLOBAL SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 7 GLOBAL SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 8 GLOBAL TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 9 GLOBAL TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 10 GLOBAL SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 11 GLOBAL SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 12 GLOBAL LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 13 GLOBAL LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 14 GLOBAL INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 15 GLOBAL INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 16 GLOBAL SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 17 GLOBAL SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 18 GLOBAL SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 19 GLOBAL SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 20 GLOBAL SCAR TREATMENT MARKET, BY REGION, $M (2014-2019)
  • TABLE 21 GLOBAL SCAR TREATMENT MARKET, BY REGION, $M (2020-2030)
  • TABLE 22 NORTH AMERICA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 23 NORTH AMERICA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 24 NORTH AMERICA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 25 NORTH AMERICA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 26 NORTH AMERICA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 27 NORTH AMERICA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 28 NORTH AMERICA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 29 NORTH AMERICA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 30 NORTH AMERICA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 31 NORTH AMERICA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 32 NORTH AMERICA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 33 NORTH AMERICA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 34 NORTH AMERICA SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 35 NORTH AMERICA SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 36 NORTH AMERICA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 37 NORTH AMERICA SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 38 U.S. SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 39 U.S. SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 40 U.S. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 41 U.S. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 42 CANADA SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 43 CANADA SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 44 CANADA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 45 CANADA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 46 EUROPE SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 47 EUROPE SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 48 EUROPE TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 49 EUROPE TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 50 EUROPE SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 51 EUROPE SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 52 EUROPE LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 53 EUROPE LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 54 EUROPE INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 55 EUROPE INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 56 EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 57 EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 58 EUROPE SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 59 EUROPE SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 60 EUROPE SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 61 EUROPE SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 62 GERMANY SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 63 GERMANY SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 64 GERMANY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 65 GERMANY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 66 FRANCE SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 67 FRANCE SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 68 FRANCE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 69 FRANCE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 70 U.K. SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 71 U.K. SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 72 U.K. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 73 U.K. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 74 ITALY SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 75 ITALY SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 76 ITALY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 77 ITALY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 78 SPAIN SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 79 SPAIN SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 80 SPAIN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 81 SPAIN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 82 APAC SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 83 APAC SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 84 APAC TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 85 APAC TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 86 APAC SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 87 APAC SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 88 APAC LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 89 APAC LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 90 APAC INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 91 APAC INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 92 APAC SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 93 APAC SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 94 APAC SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 95 APAC SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 96 APAC SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 97 APAC SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 98 CHINA SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 99 CHINA SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 100 CHINA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 101 CHINA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 102 JAPAN SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 103 JAPAN SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 104 JAPAN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 105 JAPAN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 106 INDIA SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 107 INDIA SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 108 INDIA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 109 INDIA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 110 LATAM SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 111 LATAM SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 112 LATAM TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 113 LATAM TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 114 LATAM SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 115 LATAM SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 116 LATAM LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 117 LATAM LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 118 LATAM INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 119 LATAM INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 120 LATAM SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 121 LATAM SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 122 LATAM SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 123 LATAM SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 124 LATAM SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 125 LATAM SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 126 MEA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 127 MEA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 128 MEA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 129 MEA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 130 MEA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 131 MEA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 132 MEA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 133 MEA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 134 MEA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 135 MEA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 136 MEA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 137 MEA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 138 MEA SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 139 MEA SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 140 MEA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 141 MEA SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 142 HOLOGIC INC. - AT A GLANCE
  • TABLE 143 HOLOGIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 144 CANDELA CORPORATION - AT A GLANCE
  • TABLE 145 AVITA MEDICAL LIMITED - AT A GLANCE
  • TABLE 146 AVITA MEDICAL LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 147 MOLNLYCKE HEALTH CARE AB - AT A GLANCE
  • TABLE 148 MOLNLYCKE HEALTH CARE AB - KEY FINANCIAL SUMMARY
  • TABLE 149 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) COMPANY LIMITED - AT A GLANCE
  • TABLE 150 SMITH & NEPHEW PLC - AT A GLANCE
  • TABLE 151 SMITH & NEPHEW PLC - KEY FINANCIAL SUMMARY
  • TABLE 152 REVITOL CORPORATION - AT A GLANCE
  • TABLE 153 SONOMA PHARMACEUTICALS INC. - AT A GLANCE
  • TABLE 154 SONOMA PHARMACEUTICALS INC. - KEY FINANCIAL SUMMARY
  • TABLE 155 CCA INDUSTRIES INC. - AT A GLANCE
  • TABLE 156 CCA INDUSTRIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 157 SCARGUARD LABS LLC - AT A GLANCE
  • TABLE 158 QUANTUM INC. - AT A GLANCE
  • TABLE 159 BAUSCH HEALTH COMPANIES INC. - AT A GLANCE
  • TABLE 160 BAUSCH HEALTH COMPANIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 161 MERZ PHARMA GMBH & CO. KGAA - AT A GLANCE
  • TABLE 162 JOHNSON & JOHNSON - AT A GLANCE
  • TABLE 163 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL SCAR TREATMENT MARKET SUMMARY
  • FIG 9 PORTER'S FIVE FORCES ANALYSIS
  • FIG 10 GLOBAL SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 11 GLOBAL TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 12 GLOBAL SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 13 GLOBAL LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 14 GLOBAL INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 15 GLOBAL SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 16 GLOBAL SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 17 WORLDWIDE MAJOR MARKETS FOR SCAR TREATMENTS
  • FIG 18 GLOBAL SCAR TREATMENT MARKET, BY REGION, $M (2014-2030)
  • FIG 19 NORTH AMERICA SCAR TREATMENT MARKET SNAPSHOT
  • FIG 20 NORTH AMERICA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 21 NORTH AMERICA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 22 NORTH AMERICA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 23 NORTH AMERICA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 24 NORTH AMERICA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 25 NORTH AMERICA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 26 NORTH AMERICA SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 27 NORTH AMERICA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 28 EUROPE SCAR TREATMENT MARKET SNAPSHOT
  • FIG 29 EUROPE SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 30 EUROPE TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 31 EUROPE SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 32 EUROPE LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 33 EUROPE INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 34 EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 35 EUROPE SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 36 EUROPE SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 37 APAC SCAR TREATMENT MARKET SNAPSHOT
  • FIG 38 APAC SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 39 APAC TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 40 APAC SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 41 APAC LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 42 APAC INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 43 APAC SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 44 APAC SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 45 APAC SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 46 LATAM SCAR TREATMENT MARKET SNAPSHOT
  • FIG 47 LATAM SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 48 LATAM TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 49 LATAM SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 50 LATAM LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 51 LATAM INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 52 LATAM SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 53 LATAM SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 54 LATAM SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 55 MEA SCAR TREATMENT MARKET SNAPSHOT
  • FIG 56 MEA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 57 MEA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 58 MEA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 59 MEA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 60 MEA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 61 MEA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 62 MEA SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 63 MEA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 64 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 65 HOLOGIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 66 AVITA MEDICAL LIMITED - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 67 MOLNLYCKE HEALTH CARE AB - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 68 SMITH & NEPHEW PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 69 SONOMA PHARMACEUTICALS INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2020)
  • FIG 70 CCA INDUSTRIES INC. - REVENUE SPLIT BY PRODUCT CATEGORY (2018)
  • FIG 71 BAUSCH HEALTH COMPANIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 72 JOHNSON & JOHNSON - REVENUE SPLIT BY BUSINESS SEGMENT AND GEOGRAPHY (2019)
目次
Product Code: LS10180

Title:
Scar Treatment Market Research Report: By Treatment Type (Topical, Surface, Laser, Injectable, Surgical), Scar Type (Atrophic and Acne Scar, Keloid and Hypertrophic Scar, Contracture Scar, Stretch Mark), End User (Home-Use, Hospitals, Dermatology Clinics) - Global Industry Analysis and Growth Forecast to 2030.

Due to the rising incidence of skin diseases, increasing consciousness amongst people about looks and appearance, surging awareness of scar treatment amongst the masses, rapid technological advancements and innovations in scar treatment, and the rising disposable income of people in several countries, the global scar treatment market grew rapidly during the last few years and is predicted to exhibit rapid progress in the future years as well, as per the findings of the market research company, P&S Intelligence.

As per a 2015 study carried out by the American Burn Association (ABA), 2,745 and 310 people died in residential fires and vehicle crash fires, respectively in that year. Further, 220 people died in various other fire accidents across the U.S. in 2015, as per the findings of the study. The rising incidence of such fire-related accidents has caused a sharp surge in the scar treatment market all over the globe.

The other important factor fueling the progress of the market is the increasing disposable income of people in many countries around the world. Moreover, people are becoming more conscious regarding their looks and appearance and are thus, spending more money on numerous skincare and grooming products. As per the findings of the U.S. Bureau of Labor Statistics, the personal disposable income of the people residing in the U.S. rose from $9,002.0 billion to $12,985.8 billion from 2004 to 2014 and is further predicted to grow to $19,874.5 billion in 2024.

On the basis of treatment type, the scar treatment market is classified into topical, laser, surface, surgical, and injectable categories. Amongst these, the topical division is predicted to register the fastest and highest growth in the market in the coming years. This is credited to the easier availability and lower prices of the topical scar treatment products such as oils, gels, and creams as compared to the other scar treatment products available in the market.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Treatment Type
    • 1.3.2 Market Segmentation by Scar Type
    • 1.3.3 Market Segmentation by End User
    • 1.3.4 Market Segmentation by Region
  • 1.4 Analysis Period
  • 1.5 Market Data Reporting Unit
  • 1.6 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Treatment Type
      • 4.1.1.1 Topical
        • 4.1.1.1.1 Cream
        • 4.1.1.1.2 Oil
        • 4.1.1.1.3 Gel
        • 4.1.1.1.4 Gel sheet
        • 4.1.1.1.5 Others
      • 4.1.1.2 Surface
        • 4.1.1.2.1 Dermabrasion
        • 4.1.1.2.2 Chemical peeling
        • 4.1.1.2.3 Cryosurgery
      • 4.1.1.3 Laser
        • 4.1.1.3.1 CO2 laser
        • 4.1.1.3.2 Er: YAG laser
        • 4.1.1.3.3 Pulsed-dye laser
        • 4.1.1.3.4 Others
      • 4.1.1.4 Injectable
        • 4.1.1.4.1 Tissue/dermal filler injection
        • 4.1.1.4.2 Steroid injection
      • 4.1.1.5 Surgical
    • 4.1.2 By Scar Type
      • 4.1.2.1 Atrophic and acne scar
      • 4.1.2.2 Keloid and hypertrophic scar
      • 4.1.2.3 Contracture scar
      • 4.1.2.4 Stretch mark
    • 4.1.3 By End User
      • 4.1.3.1 Home-use
      • 4.1.3.2 Hospitals
      • 4.1.3.3 Dermatology clinics
      • 4.1.3.4 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing demand for silicone-based scar treatment products
      • 4.2.1.2 Rising online retailing of scar treatment products
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing prevalence of skin diseases
      • 4.2.2.2 Rising appearance consciousness among consumers
      • 4.2.2.3 Technological advancements in scar treatment
      • 4.2.2.4 Growing awareness among individuals for scar treatment
      • 4.2.2.5 Surging disposable income
      • 4.2.2.6 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Side effects of scar treatment products and therapies
      • 4.2.3.2 High cost associated with scar treatment products
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Increasing demand for organic scar treatment products
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Buyers
    • 4.3.2 Bargaining Power of Suppliers
    • 4.3.3 Intensity of Rivalry
    • 4.3.4 Threat of New Entrants
    • 4.3.5 Threat of Substitutes
  • 4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

  • 5.1 Scar Treatment Market, by Treatment Type
    • 5.1.1 Topical Scar Treatment Market, by Type
    • 5.1.2 Surface Scar Treatment Market, by Type
    • 5.1.3 Laser Scar Treatment Market, by Type
    • 5.1.4 Injectable Scar Treatment Market, by Type
  • 5.2 Scar Treatment Market, by Scar Type
  • 5.3 Scar Treatment Market, by End User
  • 5.4 Scar Treatment Market, by Region

Chapter 6. North America Market Size and Forecast

  • 6.1 Scar Treatment Market, by Treatment Type
    • 6.1.1 Topical Scar Treatment Market, by Type
    • 6.1.2 Surface Scar Treatment Market, by Type
    • 6.1.3 Laser Scar Treatment Market, by Type
    • 6.1.4 Injectable Scar Treatment Market, by Type
  • 6.2 Scar Treatment Market, by Scar Type
  • 6.3 Scar Treatment Market, by End User
  • 6.4 Scar Treatment Market, by Country
    • 6.4.1 U.S. Scar Treatment Market
      • 6.4.1.1 Scar treatment market, by treatment type
      • 6.4.1.2 Scar treatment market, by scar type
    • 6.4.2 Canada Scar Treatment Market
      • 6.4.2.1 Scar treatment market, by treatment type
      • 6.4.2.2 Scar treatment market, by scar type

Chapter 7. Europe Market Size and Forecast

  • 7.1 Scar Treatment Market, by Treatment Type
    • 7.1.1 Topical Scar Treatment Market, by Type
    • 7.1.2 Surface Scar Treatment Market, by Type
    • 7.1.3 Laser Scar Treatment Market, by Type
    • 7.1.4 Injectable Scar Treatment Market, by Type
  • 7.2 Scar Treatment Market, by Scar Type
  • 7.3 Scar Treatment Market, by End User
  • 7.4 Scar Treatment Market, by Country
    • 7.4.1 Germany Scar Treatment Market
      • 7.4.1.1 Scar treatment market, by treatment type
      • 7.4.1.2 Scar treatment market, by scar type
    • 7.4.2 France Scar Treatment Market
      • 7.4.2.1 Scar treatment market, by treatment type
      • 7.4.2.2 Scar treatment market, by scar type
    • 7.4.3 U.K. Scar Treatment Market
      • 7.4.3.1 Scar treatment market, by treatment type
      • 7.4.3.2 Scar treatment market, by scar type
    • 7.4.4 Italy Scar Treatment Market
      • 7.4.4.1 Scar treatment market, by treatment type
      • 7.4.4.2 Scar treatment market, by scar type
    • 7.4.5 Spain Scar Treatment Market
      • 7.4.5.1 Scar treatment market, by treatment type
      • 7.4.5.2 Scar treatment market, by scar type

Chapter 8. APAC Market Size and Forecast

  • 8.1 Scar Treatment Market, by Treatment Type
    • 8.1.1 Topical Scar Treatment Market, by Type
    • 8.1.2 Surface Scar Treatment Market, by Type
    • 8.1.3 Laser Scar Treatment Market, by Type
    • 8.1.4 Injectable Scar Treatment Market, by Type
  • 8.2 Scar Treatment Market, by Scar Type
  • 8.3 Scar Treatment Market, by End User
  • 8.4 Scar Treatment Market, by Country
    • 8.4.1 China Scar Treatment Market
      • 8.4.1.1 Scar treatment market, by treatment type
      • 8.4.1.2 Scar treatment market, by scar type
    • 8.4.2 Japan Scar Treatment Market
      • 8.4.2.1 Scar treatment market, by treatment type
      • 8.4.2.2 Scar treatment market, by scar type
    • 8.4.3 India Scar Treatment Market
      • 8.4.3.1 Scar treatment market, by treatment type
      • 8.4.3.2 Scar treatment market, by scar type

Chapter 9. LATAM Market Size and Forecast

  • 9.1 Scar Treatment Market, by Treatment Type
    • 9.1.1 Topical Scar Treatment Market, by Type
    • 9.1.2 Surface Scar Treatment Market, by Type
    • 9.1.3 Laser Scar Treatment Market, by Type
    • 9.1.4 Injectable Scar Treatment Market, by Type
  • 9.2 Scar Treatment Market, by Scar Type
  • 9.3 Scar Treatment Market, by End User
  • 9.4 Scar Treatment Market, by Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 Scar Treatment Market, by Treatment Type
    • 10.1.1 Topical Scar Treatment Market, by Type
    • 10.1.2 Surface Scar Treatment Market, by Type
    • 10.1.3 Laser Scar Treatment Market, by Type
    • 10.1.4 Injectable Scar Treatment Market, by Type
  • 10.2 Scar Treatment Market, by Scar Type
  • 10.3 Scar Treatment Market, by End User
  • 10.4 Scar Treatment Market, by Country

Chapter 11. Competitive Landscape

  • 11.1 Product Benchmarking of Key Players
  • 11.2 Strategic Developments
    • 11.2.1 Product Launches and Approvals
    • 11.2.2 Acquisitions
    • 11.2.3 Other Developments

Chapter 12. Company Profiles

  • 12.1 Hologic Inc.
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Candela Corporation
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
  • 12.3 Avita Medical Limited
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Molnlycke Health Care AB
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 Shanghai Fosun Pharmaceutical (Group) Company Limited
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
  • 12.6 Smith & Nephew plc
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 Revitol Corporation
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
  • 12.8 Sonoma Pharmaceuticals Inc.
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 CCA Industries Inc.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary
  • 12.10 Scarguard Labs LLC
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
  • 12.11 Quantum Inc.
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
  • 12.12 Bausch Health Companies Inc.
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
    • 12.12.3 Key Financial Summary
  • 12.13 Merz Pharma GmbH & Co. KGaA
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 Johnson & Johnson
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
    • 12.14.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.